A University of Calgary-led international research team has identified a genetic factor that may explain why people respond so differently to opioid pain medications, and why some individuals face greater risk of side effects including dependency. The study, published in Neuron, involved researchers from the Faculty of Veterinary Medicine (UCVM), Cumming School of Medicine (CSM), and Hotchkiss Brain Institute (HBI), and provides new clinical insight that could lead to personalized strategies to optimize pain management.
This article was originally published on MedicalXpress.com

